Sclerostin aggravates cardiac remodeling after myocardial infarction by inhibition of Wnt/β-catenin signaling pathway

BACKGROUND: The serum levels of sclerostin (SOST) are significant elevated in patients with pathological cardiac remodeling after myocardial infarction (MI). However, the mechanisms of SOST in cardiac remodeling remain largely uncharacterized. METHODS: Collecting patients with MI who presented with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Shuxin, Wei, Jinyi, Chen, Peipei, Chen, Fangliang, Yang, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186236/
https://www.ncbi.nlm.nih.gov/pubmed/35693595
http://dx.doi.org/10.21037/jtd-22-473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186236/
https://www.ncbi.nlm.nih.gov/pubmed/35693595
http://dx.doi.org/10.21037/jtd-22-473

Ejemplares similares